These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7845117)

  • 1. Hepatitis B virus infection without immunological markers after open-heart surgery.
    Rasenack JW; Schlayer HJ; Hettler F; Peters T; Preisler-Adams S; Gerok W
    Lancet; 1995 Feb; 345(8946):355-7. PubMed ID: 7845117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt.
    Helaly GF; El Ghazzawi EF; Shawky SM; Farag FM
    J Infect Public Health; 2015; 8(6):562-9. PubMed ID: 26026236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of HBV DNA by PCR in serum from an HBsAg negative blood donor implicated in cases of post-transfusion hepatitis B.
    Norder H; Hammas B; Larsen J; Skaug K; Magnius LO
    Arch Virol Suppl; 1992; 4():116-8. PubMed ID: 1450678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of donors who transmit posttransfusion hepatitis.
    Tabor E; Hoofnagle JH; Smallwood LA; Drucker JA; Pineda-Tamondong GC; Ni LY; Greenwalt TJ; Barker LF; Gerety RJ
    Transfusion; 1979; 19(6):725-31. PubMed ID: 230620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adefovir is effective to promote development of immunity to donor origin hepatitis B virus in an allogeneic transplant recipient: a case report.
    Yaşar DG; Suyanı E; Özenirler S; Sucak GT
    Transplant Proc; 2013 Mar; 45(2):833-4. PubMed ID: 23498831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
    Motta JS; Mello FC; Lago BV; Perez RM; Gomes SA; Figueiredo FF
    J Gastroenterol Hepatol; 2010 Jan; 25(1):101-6. PubMed ID: 19817965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of hepatitis B virus by HBV-negative blood transfusion.
    Elghouzzi MH; Couroucé AM; Magnius LO; Lunel F; Lapierre V
    Lancet; 1995 Oct; 346(8980):964. PubMed ID: 7564744
    [No Abstract]   [Full Text] [Related]  

  • 10. Establishment of a simple model for hepatitis B virus infection status based on trait marker from quantitative measurement of serum markers.
    Ningyu Z; Ying Z; Hui L
    J Med Virol; 2015 Jun; 87(6):1008-12. PubMed ID: 25716104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of HBV infectivity in blood donors detected by the dot blot hybridisation assay.
    Nagaraju K; Misra S; Saraswat S; Choudhary N; Masih B; Ramesh V; Naik S
    Vox Sang; 1994; 67(2):183-6. PubMed ID: 7801609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the hepatitis B virus precore and ORF-X sequences in patients with antibody to hepatitis B e antigen with and without normal ALT levels.
    Cabrerizo M; Bartolomé J; Iñigo ER; López-Alcorocho JM; Cotonat T; Carreño V
    J Med Virol; 1998 Dec; 56(4):294-9. PubMed ID: 9829632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of hepatitis B X antigen, antibodies to X antigen, and antibodies to the viral polymerase during hepatitis B virus infection.
    Horiike N; Blumberg BS; Feitelson MA
    J Infect Dis; 1991 Dec; 164(6):1104-12. PubMed ID: 1955710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA; Stramer SL; Kuhns MC; Schlauder GG
    Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen.
    Wang JT; Wang TH; Sheu JC; Shih LN; Lin JT; Chen DS
    J Infect Dis; 1991 Feb; 163(2):397-9. PubMed ID: 1988524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B variants among Egyptian patients undergoing hemodialysis.
    Abdel-Maksoud NHM; El-Shamy A; Fawzy M; Gomaa HHA; Eltarabilli MMA
    Microbiol Immunol; 2019 Feb; 63(2):77-84. PubMed ID: 30680771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis.
    Baginski I; Chemin I; Hantz O; Pichoud C; Jullien AM; Chevre JC; Li JS; Vitvitski L; Sninsky JJ; Trepo C
    Transfusion; 1992; 32(3):215-20. PubMed ID: 1557801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.